One Shot Ultra 8, Cattle Vaccine,50ds

In stock

SKU:
U6005077
Model Number:
10009927
Brand/Manufacturer:
One Shot Ultra
$236.99
/ EA
One Shot Ultra 8 is for vaccination of healthy cattle as an aid in preventing blackleg caused by clostridium chauvoei, malignant edema caused by Cl. septicum, bacillary hemoglobinuria caused by Cl. haemolyticum, black disease caused by Cl. novyi, gas-gangrene caused by Cl. sordellii, enterotoxemia and enteritis caused by Cl.perfringens types B, C, D and bovine pneumonia caused by mannheimia (pasteurella) haemolytica type A1. Although Cl. perfringens type B is not a significant problem in north America, immunity is provided by the beta toxoid of type C and the epsilon toxoid of type D. The freeze-dried component is a preparation of inactivated whole cultures of M. haemolytica propagated to increase the production of leukotoxin and capsular and cell-associated antigens. The liquid component consists of killed, standardized cultures of Cl. chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii and Cl. perfringens types C and D, with a special, water-soluble adjuvant (Stimugen®) to enhance the immune response.
Compositions
: Formaldehyde, Saponin, Aluminum Potassium Sulfate, Clostridium Haemolyticum, Clostridium Sordellii, Clostridium Novyi, Clostridium Chauvoei, Clostridium Perfringens Type D, Clostridium Septicum, Clostridium Perfringens Type C, Pasteurella Haemolytica
Form
: Liquid
Container Type
: Vial
Product Category
: Footrot Vaccines
Net Content
: 50 Dose
  • Helps prevent eight clostridial diseases (including diseases caused by CI. haemolyticum and CI perfringens Types B, C and D), which continue to be of economic importance in cattle
  • Helps protect against the primary cause of respiratory death in cattle, shipping fever and pneumonia caused by Mannheimia haemolytica type A1
  • Produces leukotoxin and whole-cell antibody responses, helping provide protection needed to withstand Mannheimia haemolytica challenge
  • Contains Stimugen®, a patented, water-soluble adjuvant that enhances the immune response with minimal risk of injection-site reactions
  • No age restrictions on use
  • Subcutaneous (SC) dose is 2 mL followed by a second 2 mL dose of UltraChoice® 8 four to six weeks later
StoreAvailabilityPhoneDistance